Your browser doesn't support javascript.
loading
Author Correction: Fructose-1,6-bisphosphatase 1 dephosphorylates and inhibits TERT for tumor suppression.
Li, Min; Wang, Zheng; Tao, Jingjing; Jiang, Hongfei; Yang, Huang; Guo, Dong; Zhao, Hong; He, Xuxiao; Luo, Shudi; Jiang, Xiaoming; Yuan, Li; Xiao, Liwei; He, Haiyan; Yu, Rilei; Fang, Jing; Liang, Tingbo; Mao, Zhengwei; Xu, Daqian; Lu, Zhimin.
Afiliación
  • Li M; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Wang Z; Cancer Center, Zhejiang University, Hangzhou, China.
  • Tao J; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Jiang H; Cancer Center, Zhejiang University, Hangzhou, China.
  • Yang H; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Guo D; Cancer Center, Zhejiang University, Hangzhou, China.
  • Zhao H; The Affiliated Hospital of Qingdao University and Qingdao Cancer Institute, Qingdao, China.
  • He X; MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, China.
  • Luo S; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Jiang X; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Yuan L; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Xiao L; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • He H; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Yu R; Cancer Center, Zhejiang University, Hangzhou, China.
  • Fang J; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Liang T; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Mao Z; Cancer Center, Zhejiang University, Hangzhou, China.
  • Xu D; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Lu Z; Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Nat Chem Biol ; 2024 Apr 22.
Article en En | MEDLINE | ID: mdl-38649455

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Nat Chem Biol Asunto de la revista: BIOLOGIA / QUIMICA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Nat Chem Biol Asunto de la revista: BIOLOGIA / QUIMICA Año: 2024 Tipo del documento: Article País de afiliación: China